1999
DOI: 10.1046/j.1365-2036.1999.0612b.x
|View full text |Cite
|
Sign up to set email alerts
|

Reply — Efficacy of 1‐week ranitidine‐ bismuth‐citrate (RBC)‐based triple therapy for eradication of Helicobacter pylori infection

Abstract: Ef®cacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection SIRS, We read the recent article by Hoffman et al. on the evaluation of a RBC-based triple regimen administered for only 1-week to eradicate Helicobacter pylori infection.1 They obtained excellent eradication rates (86% with ITT and 91% with PP) on a small number of patients (n 50) and therefore emphasize the effectiveness of this short-term triple therapy. The authors present their study as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 7 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?